David H. Raulet
David H. Raulet is an immunologist who specializes in studying the role of natural killer cells. He is a professor in the Department of Molecular and Cell Biology at the University of California, Berkeley where he also holds the Esther and Wendy Schekman Chair in cancer biology. He was elected to the National Academy of Sciences in 2019. Raulet is also the co-founder of Dragonfly Therapeutics, a company that seeks to use natural killer cells for cancer immunotherapy. Provided by Wikipedia-
1
-
2
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
Published 2017-12-01Get full text
Article -
3
Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages
Published 2018-05-01Get full text
Article -
4
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
Published 2016-11-01Get full text
Article -
5
Binary outcomes of enhancer activity underlie stable random monoallelic expression
Published 2022-05-01Get full text
Article -
6
Regulated accessibility of variable region genes may control developmentally ordered T cell receptor [gamma] gene rearrangement
Published 2006Other Authors: “…David H. Raulet.…”
Get full text
Thesis